Table 2.

Treatment compliance.

Treatment summary	Arm 1	Arm 2
	FOLFOX + Bevacizumab	FOLFOXIRI + Bevacizumab
	N = 10	N = 10
Total number of chemo cycles given
1	1 (10%)	0 (0%)
3	0 (0%)	1 (10%)
4	1 (10%)	0 (0%)
6	8 (80%)	9 (90%)
Total number of Bevazizumab cycles given
1	1 (10%)	0 (0%)
3	0 (0%)	1 (10%)
4	1 (10%)	0 (0%)
6	8 (80%)	9 (90%)
Early treatment discontinuation
No	8 (80%)	9 (90%)
Yes	2 (20%)	1 (10%)
SAE (Myocardial infarction)	1 (10%)	0 (0%)
No response following 3 cycles	0 (0%)	1 (10%)
Suicide	1 (10%)	0 (0%)